{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:01:47Z","timestamp":1793397707397,"version":"4.5.0"},"reference-count":217,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Anterior uveitis, inflammation of the anterior chamber and related structures, is a cohort of diseases that can present to almost any general or sub-specialty Ophthalmology practice. Its features classically involve anterior chamber cell and flare. Below the surface of these two signs exist a panoply of diagnoses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Body<\/jats:title>\n                <jats:p>The purpose of this review is to provide a general framework for diagnoses of anterior uveitis that are often missed as well as non-uveitic pathologies that often mimic anterior uveitis. Diagnostic deviation in either direction can have vision-threatening and rarely life-threatening consequences for patients. Using a comprehensive literature review we have collected a broad spectrum of etiologies of anterior uveitis that are easily missed and non-uveitic pathologies that can masquerade as anterior uveitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We present a focused review on specific misdiagnosed anterior uveitis pathologies and some of the conditions that can masquerade as anterior uveitis and scleritis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12348-024-00396-z","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T03:29:13Z","timestamp":1712719753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mimickers of anterior uveitis, scleritis and misdiagnoses- tips and tricks for the cornea specialist"],"prefix":"10.1186","volume":"14","author":[{"given":"Sonny","family":"Caplash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Paez-Escamilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Westcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal K.","family":"Dansingani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Indermill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nacima","family":"Kisma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Frau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose-Alain","family":"Sahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Bodaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Jhanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Helene","family":"Errera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"396_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature Working, G (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509\u2013516","journal-title":"Am J Ophthalmol"},{"key":"396_CR2","unstructured":"Russell W. Read, N.A., Ralph D. Levinson, P. Kumar Rao, H. Nida Sen, Jonathan D. Walker, Daniel V. Vasconcelos-Santos. 2020-2021 BASIC AND CLINICAL SCIENCE COURSE (BCSC), SECTION 09: Uveitis and Ocular inflammation, (American Academy of Ophthalmology, 2017)"},{"key":"396_CR3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group, P (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336\u2013341","journal-title":"Int J Surg"},{"key":"396_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.iio.0000155938.83083.94","volume":"45","author":"D Wakefield","year":"2005","unstructured":"Wakefield D, Chang JH (2005) Epidemiology of uveitis. Int Ophthalmol Clin 45:1\u201313","journal-title":"Int Ophthalmol Clin"},{"key":"396_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","volume":"26","author":"T Tsirouki","year":"2018","unstructured":"Tsirouki T et al (2018) A focus on the epidemiology of uveitis. Ocul Immunol Inflamm 26:2\u201316","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR6","first-page":"295","volume":"24","author":"O Badeeb","year":"1992","unstructured":"Badeeb O et al (1992) Leukemic infiltrate versus anterior uveitis. Ann Ophthalmol 24:295\u2013298","journal-title":"Ann Ophthalmol"},{"key":"396_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/09273948.2021.1878233","volume":"29","author":"D Carbonell","year":"2021","unstructured":"Carbonell D et al (2021) Consensus recommendations for the diagnosis of vitreoretinal lymphoma. Ocul Immunol Inflamm 29:507\u2013520","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR8","doi-asserted-by":"publisher","first-page":"101053","DOI":"10.1016\/j.preteyeres.2022.101053","volume":"90","author":"H Takase","year":"2022","unstructured":"Takase H et al (2022) Challenges in the diagnosis and management of vitreoretinal lymphoma - clinical and basic approaches. Prog Retin Eye Res 90:101053","journal-title":"Prog Retin Eye Res"},{"key":"396_CR9","doi-asserted-by":"crossref","unstructured":"Nguyen QL, Reynolds SB, Piri N, Rivas Perez HL (2021) Ophthalmic anterior segment metastasis masquerading as uveitis. BMJ Case Rep 14","DOI":"10.1136\/bcr-2020-236405"},{"key":"396_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/08820530500350498","volume":"21","author":"JY Choi","year":"2006","unstructured":"Choi JY, Kafkala C, Foster CS (2006) Primary intraocular lymphoma: a review. Seminars Ophthalmol 21:125\u2013133","journal-title":"Seminars Ophthalmol"},{"key":"396_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4274\/tjo.92609","volume":"47","author":"Z Ayhan","year":"2017","unstructured":"Ayhan Z, YildirimKarabag R, Alacacioglu I, Kaynak S, Kocak N (2017) Rare clinical sign of hodgkin\u2019s lymphoma: ocular involvement. Turk J Ophthalmol 47:110\u2013112","journal-title":"Turk J Ophthalmol"},{"key":"396_CR12","first-page":"292","volume":"12","author":"DH Verity","year":"2000","unstructured":"Verity DH, Graham EM, Carr R, van der Walt JD, Stanford MR (2000) Hypopyon uveitis and iris nodules in non-Hodgkin\u2019s lymphoma: ocular relapse during systemic remission. Clin Oncol (R Coll Radiol) 12:292\u2013294","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"396_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000445119","volume":"2","author":"AC Gauthier","year":"2016","unstructured":"Gauthier AC, Nguyen A, Munday WR, Xu ML, Materin MA (2016) Anterior Chamber Non-Hodgkin Lymphoma of the Iris Masquerading as Uveitis-Glaucoma-Hyphema Syndrome. Ocular Oncol Pathol 2:230\u2013233","journal-title":"Ocular Oncol Pathol"},{"key":"396_CR14","doi-asserted-by":"publisher","first-page":"100761","DOI":"10.1016\/j.preteyeres.2019.05.002","volume":"72","author":"S Touhami","year":"2019","unstructured":"Touhami S et al (2019) Neoplasia and intraocular inflammation: from masquerade syndromes to immunotherapy-induced uveitis. Prog Retin Eye Res 72:100761","journal-title":"Prog Retin Eye Res"},{"key":"396_CR15","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.ophtha.2008.07.003","volume":"115","author":"CL Shields","year":"2008","unstructured":"Shields CL, Ghassemi F, Tuncer S, Thangappan A, Shields JA (2008) Clinical spectrum of diffuse infiltrating retinoblastoma in 34 consecutive eyes. Ophthalmology 115:2253\u20132258","journal-title":"Ophthalmology"},{"key":"396_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0002-9394(68)93096-1","volume":"65","author":"WW Richards","year":"1968","unstructured":"Richards WW (1968) Retinoblastoma simulating uveitis. Am J Ophthalmol 65:427\u2013431","journal-title":"Am J Ophthalmol"},{"key":"396_CR17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/cyto.b.21361","volume":"92","author":"S Monsalvo","year":"2017","unstructured":"Monsalvo S et al (2017) Unilateral uveitis masquerade syndrome caused by diffuse large B-cell lymphoma diagnosed using multiparametric flow cytometry of the aqueous humor. Cytometry Part B, Clinical Cytometry 92:286\u2013290","journal-title":"Cytometry Part B, Clinical Cytometry"},{"key":"396_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/09273948.2014.925124","volume":"24","author":"J Bell","year":"2016","unstructured":"Bell J et al (2016) Concurrent uveal and vitreoretinal lymphoma masquerading as anterior uveitis. Ocul Immunol Inflamm 24:120\u2013123","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR19","doi-asserted-by":"crossref","unstructured":"Batis V, Shuttleworth J, Shuttleworth G, Williams GS (2019) Diagnostic dilemma of ocular lymphoma. BMJ CaseRep 12","DOI":"10.1136\/bcr-2019-229513"},{"key":"396_CR20","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/medicina58030456","volume":"58","author":"M Denier","year":"2022","unstructured":"Denier M et al (2022) Hidden in the eyes-recurrence of systemic hemopathies reportedly \u201cin remission\u201d: six cases and review of literature. Medicina (Kaunas) 58:456","journal-title":"Medicina (Kaunas)"},{"key":"396_CR21","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.4103\/IJO.IJO_3049_22","volume":"71","author":"C Evereklioglu","year":"2023","unstructured":"Evereklioglu C et al (2023) Comments on: Relapse of acute lymphoblastic leukemia presenting as masquerade uveitis with hypopyon in a child. Indian J Ophthalmol 71:2314\u20132315","journal-title":"Indian J Ophthalmol"},{"key":"396_CR22","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.4103\/ijo.IJO_921_22","volume":"70","author":"O Rehman","year":"2022","unstructured":"Rehman O et al (2022) Relapse of acute lymphoblastic leukemia presenting as masquerade uveitis with hypopyon in a child. Indian J Ophthalmol 70:2732\u20133","journal-title":"Indian J Ophthalmol"},{"key":"396_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5693\/djo.02.2022.03.001","volume":"28","author":"YC Hung","year":"2022","unstructured":"Hung YC, Wilkinson B, Chong CF (2022) A case of aggressive natural killer cell leukemia. Digit J Ophthalmol 28:116\u2013118","journal-title":"Digit J Ophthalmol"},{"key":"396_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000475718","volume":"4","author":"M Tyagi","year":"2017","unstructured":"Tyagi M et al (2017) Bilateral Hypopyon Uveitis in Chronic Myeloid Leukemia. Ocul Oncol Pathol 4:12\u201315","journal-title":"Ocul Oncol Pathol"},{"key":"396_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/09273940802411437","volume":"16","author":"S Sudharshan","year":"2008","unstructured":"Sudharshan S, Kumari A, Biswas J (2008) Bilateral hypopyon as the presenting feature of chronic myeloid leukemia. Ocular Immunol Inflamm 16:244\u2013246","journal-title":"Ocular Immunol Inflamm"},{"key":"396_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12348-022-00302-5","volume":"12","author":"G Zamani","year":"2022","unstructured":"Zamani G et al (2022) Intraocular lymphoma masquerading as unilateral hypopyon anterior uveitis: a case report. J Ophthalmic Inflamm Infect 12:25","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"396_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","volume":"50","author":"S Li","year":"2018","unstructured":"Li S, Young KH, Medeiros LJ (2018) Diffuse large B-cell lymphoma. Pathology 50:74\u201387","journal-title":"Pathology"},{"key":"396_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0161-6420(97)30221-8","volume":"104","author":"JB Mizener","year":"1997","unstructured":"Mizener JB, Podhajsky P, Hayreh SS (1997) Ocular ischemic syndrome. Ophthalmology 104:859\u2013864","journal-title":"Ophthalmology"},{"key":"396_CR29","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1136\/bjo.84.12.1428","volume":"84","author":"R Malhotra","year":"2000","unstructured":"Malhotra R, Gregory-Evans K (2000) Management of ocular ischaemic syndrome. Br J Ophthalmol 84:1428\u20131431","journal-title":"Br J Ophthalmol"},{"key":"396_CR30","unstructured":"Gary C. Brown, S.S., Melissa M. Brown. Ocular Ischemic Syndrome. in Ryan's Retina, Vol. 6 (ed. Andrew P. Schachat, S.R.S., David R. Hinton, C.P. Wilkinson, Peter Wiedermann) 1227-1239 (Elsevier, 2018)"},{"key":"396_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00131023","volume":"11","author":"GC Brown","year":"1988","unstructured":"Brown GC, Magargal LE (1988) The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol 11:239\u2013251","journal-title":"Int Ophthalmol"},{"key":"396_CR32","first-page":"302","volume":"38","author":"GC Brown","year":"1986","unstructured":"Brown GC, Brown MM, Magargal LE (1986) The ocular ischemic syndrome and neovascularization. Trans Pa Acad Ophthalmol Otolaryngol 38:302\u2013306","journal-title":"Trans Pa Acad Ophthalmol Otolaryngol"},{"key":"396_CR33","first-page":"306","volume":"119","author":"RJ Casson","year":"2001","unstructured":"Casson RJ, Fleming FK, Shaikh A, James B (2001) Bilateral ocular ischemic syndrome secondary to giant cell arteritis. Arch Ophthalmol 119:306\u2013307","journal-title":"Arch Ophthalmol"},{"key":"396_CR34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/ICB.0000000000000129","volume":"9","author":"E Papavasileiou","year":"2015","unstructured":"Papavasileiou E, Sobrin L, Papaliodis GN (2015) Ocular ischemic syndrome presenting as retinal vasculitis in a patient with moyamoya syndrome. Retinal Cases Brief Rep 9:170\u2013172","journal-title":"Retinal Cases Brief Rep"},{"key":"396_CR35","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fneur.2020.00338","volume":"11","author":"YY Wang","year":"2020","unstructured":"Wang YY et al (2020) Moyamoya disease associated with morning glory disc anomaly and other ophthalmic findings: a mini-review. Front Neurol 11:338","journal-title":"Front Neurol"},{"key":"396_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0002-9394(98)00313-4","volume":"127","author":"JM Hwang","year":"1999","unstructured":"Hwang JM et al (1999) Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment. Am J Ophthalmol 127:102\u2013104","journal-title":"Am J Ophthalmol"},{"key":"396_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00006982-200102000-00017","volume":"21","author":"M Worrall","year":"2001","unstructured":"Worrall M, Atebara N, Meredith T, Mann ES (2001) Bilateral ocular ischemic syndrome in Takayasu disease. Retina 21:75\u201376","journal-title":"Retina"},{"key":"396_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3109\/08820538.2015.1046558","volume":"32","author":"CM Salinas-La Rosa","year":"2017","unstructured":"Salinas-La Rosa CM (2017) Malignant Transformation of Optic Nerve Melanocytoma into Melanoma Associated with Ocular Ischemic Syndrome and Oculocardiac Reflex: Case Report and Review of the Literature. Seminars Ophthalmol 32:253\u2013256","journal-title":"Seminars Ophthalmol"},{"key":"396_CR39","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1097\/IAE.0b013e3181fe540b","volume":"31","author":"J Peter","year":"2011","unstructured":"Peter J et al (2011) Ocular manifestations of Takayasu arteritis: a cross-sectional study. Retina 31:1170\u20131178","journal-title":"Retina"},{"key":"396_CR40","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2147\/OPTH.S12331","volume":"4","author":"J Peter","year":"2010","unstructured":"Peter J, David S, Joseph G, Horo S, Danda D (2010) Hypoperfusive and hypertensive ocular manifestations in Takayasu arteritis. Clin Ophthalmol 4:1173\u20131176","journal-title":"Clin Ophthalmol"},{"key":"396_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5758\/vsi.200031","volume":"36","author":"RB Larrazabal","year":"2020","unstructured":"Larrazabal RB, Chiu HHC, Magbitang-Santiago AT (2020) Takayasu arteritis presenting as bilateral ocular ischemic syndrome. Vasc Special Int 36:163\u2013169","journal-title":"Vasc Special Int"},{"key":"396_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00296-006-0194-4","volume":"27","author":"OG Koz","year":"2007","unstructured":"Koz OG et al (2007) Bilateral ocular ischemic syndrome as an initial manifestation of Takayasu\u2019s arteritis associated with carotid steal syndrome. Rheumatol Int 27:299\u2013302","journal-title":"Rheumatol Int"},{"key":"396_CR43","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/j.jcjo.2018.08.018","volume":"54","author":"R Anguita","year":"2019","unstructured":"Anguita R, Nazar C, Kobus R, Salinas A, Astete M (2019) Bilateral ocular ischemic syndrome as a manifestation of Takayasu arteritis in children. Can J Ophthalmol 54:e105\u2013e108","journal-title":"Can J Ophthalmol"},{"key":"396_CR44","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/WNO.0b013e3181dee914","volume":"30","author":"Y Tang","year":"2010","unstructured":"Tang Y, Luo D, Peng W, Huang F, Peng Y (2010) Ocular ischemic syndrome secondary to carotid artery occlusion as a late complication of radiotherapy of nasopharyngeal carcinoma. J Neuro-ophthalmology 30:315\u2013320","journal-title":"J Neuro-ophthalmology"},{"key":"396_CR45","first-page":"1","volume":"231","author":"M Dhooge","year":"1989","unstructured":"Dhooge M, de Laey JJ (1989) The ocular ischemic syndrome. Bulletin de la Societe belge d\u2019ophtalmologie 231:1\u201313","journal-title":"Bulletin de la Societe belge d'ophtalmologie"},{"key":"396_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s40266-018-0545-3","volume":"35","author":"E Akinsoji","year":"2018","unstructured":"Akinsoji E, Goldhardt R, Galor A (2018) A glimpse into uveitis in the aging eye: pathophysiology, clinical presentation and treatment considerations. Drugs Aging 35:399\u2013408","journal-title":"Drugs Aging"},{"key":"396_CR47","first-page":"1","volume":"21","author":"JR Gonder","year":"1986","unstructured":"Gonder JR (1986) The ocular ischemic syndrome. Can J Ophthalmol 21:1\u20132","journal-title":"Can J Ophthalmol"},{"key":"396_CR48","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0161-6420(00)00499-1","volume":"108","author":"A Rothova","year":"2001","unstructured":"Rothova A, Ooijman F, Kerkhoff F, Van Der Lelij A, Lokhorst HM (2001) Uveitis masquerade syndromes. Ophthalmology 108:386\u2013399","journal-title":"Ophthalmology"},{"key":"396_CR49","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/bjo.69.9.681","volume":"69","author":"NA Jacobs","year":"1985","unstructured":"Jacobs NA, Ridgway AE (1985) Syndrome of ischaemic ocular inflammation: six cases and a review. Br J Ophthalmol 69:681\u2013687","journal-title":"Br J Ophthalmol"},{"key":"396_CR50","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/09273948.2012.745882","volume":"21","author":"T Karaconji","year":"2013","unstructured":"Karaconji T, Maconochie Z, McCluskey P (2013) Acute anterior uveitis in Sydney. Ocul Immunol Inflamm 21:108\u2013114","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR51","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ajo.2014.10.030","volume":"159","author":"A Moradi","year":"2015","unstructured":"Moradi A et al (2015) Clinical features and incidence rates of ocular complications in patients with ocular syphilis. Am J Ophthalmol 159:334\u2013343 e331","journal-title":"Am J Ophthalmol"},{"key":"396_CR52","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.1167\/iovs.14-14559","volume":"55","author":"RG Mathew","year":"2014","unstructured":"Mathew RG, Goh BT, Westcott MC (2014) British Ocular Syphilis Study (BOSS): 2-year national surveillance study of intraocular inflammation secondary to ocular syphilis. Invest Ophthalmol Vis Sci 55:5394\u20135400","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"396_CR53","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3201\/eid2402.171167","volume":"24","author":"AC Pratas","year":"2018","unstructured":"Pratas AC et al (2018) Increase in Ocular Syphilis Cases at Ophthalmologic Reference Center, France, 2012\u20132015. Emerg Infect Dis 24:193\u2013200","journal-title":"Emerg Infect Dis"},{"key":"396_CR54","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.ophtha.2017.06.003","volume":"124","author":"F Hoogewoud","year":"2017","unstructured":"Hoogewoud F et al (2017) Prognostic Factors in Syphilitic Uveitis. Ophthalmology 124:1808\u20131816","journal-title":"Ophthalmology"},{"key":"396_CR55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0896-1549(02)00032-9","volume":"15","author":"AM Berrocal","year":"2002","unstructured":"Berrocal AM, Davis JL (2002) Uveitis following intraocular surgery. Ophthalmol Clin North Am 15:357\u2013364, vii","journal-title":"Ophthalmol Clin North Am"},{"key":"396_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3928\/15428877-20060701-10","volume":"37","author":"JK Nguyen","year":"2006","unstructured":"Nguyen JK, Fung AE, Flynn HW Jr, Scott IU (2006) Hypopyon and pseudoendophthalmitis associated with chronic vitreous hemorrhage. Ophthalmic Surgery Lasers Imaging 37:317\u2013319","journal-title":"Ophthalmic Surgery Lasers Imaging"},{"key":"396_CR57","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10792-012-9691-5","volume":"33","author":"M Shunmugam","year":"2013","unstructured":"Shunmugam M, Hugkulstone CE, Wong R, Williamson TH (2013) Consecutive toxic anterior segment syndrome in combined phaco-vitrectomy. Int Ophthalmol 33:289\u2013290","journal-title":"Int Ophthalmol"},{"key":"396_CR58","doi-asserted-by":"publisher","first-page":"803","DOI":"10.5301\/ejo.5000116","volume":"22","author":"E Moisseiev","year":"2012","unstructured":"Moisseiev E, Barak A (2012) Toxic anterior segment syndrome outbreak after vitrectomy and silicone oil injection. Eur J Ophthalmol 22:803\u2013807","journal-title":"Eur J Ophthalmol"},{"key":"396_CR59","doi-asserted-by":"publisher","first-page":"330","DOI":"10.5935\/0004-2749.20160094","volume":"79","author":"N Sevimli","year":"2016","unstructured":"Sevimli N et al (2016) Toxic anterior segment syndrome following deep anterior lamellar keratoplasty. Arquivos Brasileiros de Oftalmologia 79:330\u2013332","journal-title":"Arquivos Brasileiros de Oftalmologia"},{"key":"396_CR60","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1159\/000345531","volume":"3","author":"N Sorkin","year":"2012","unstructured":"Sorkin N, Varssano D (2012) Toxic anterior segment syndrome following a triple descemet\u2019s stripping automated endothelial keratoplasty procedure. Case Rep Ophthalmol 3:406\u2013409","journal-title":"Case Rep Ophthalmol"},{"key":"396_CR61","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1001\/archopht.126.12.1677","volume":"126","author":"P Maier","year":"2008","unstructured":"Maier P, Birnbaum F, Bohringer D, Reinhard T (2008) Toxic anterior segment syndrome following penetrating keratoplasty. Arch Ophthalmol 126:1677\u20131681","journal-title":"Arch Ophthalmol"},{"key":"396_CR62","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.survophthal.2019.01.009","volume":"64","author":"E Hernandez-Bogantes","year":"2019","unstructured":"Hernandez-Bogantes E et al (2019) Toxic anterior segment syndrome: a review. Surv Ophthalmol 64:463\u2013476","journal-title":"Surv Ophthalmol"},{"key":"396_CR63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/00004397-200001000-00007","volume":"40","author":"CM Samson","year":"2000","unstructured":"Samson CM, Foster CS (2000) Chronic postoperative endophthalmitis. Int Ophthalmol Clin 40:57\u201367","journal-title":"Int Ophthalmol Clin"},{"key":"396_CR64","first-page":"313248","volume":"2012","author":"F Maalouf","year":"2012","unstructured":"Maalouf F, Abdulaal M, Hamam RN (2012) Chronic postoperative endophthalmitis: a review of clinical characteristics, microbiology, treatment strategies, and outcomes. Int J Inflamm 2012:313248","journal-title":"Int J Inflamm"},{"key":"396_CR65","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00417-019-04598-3","volume":"258","author":"EN Nche","year":"2020","unstructured":"Nche EN, Amer R (2020) Lens-induced uveitis: an update. Graefes Arch Clin Exp Ophthalmol 258:1359\u20131365","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"396_CR66","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/archopht.1987.01060110128046","volume":"105","author":"JT Rosenbaum","year":"1987","unstructured":"Rosenbaum JT, Samples JR, Seymour B, Langlois L, David L (1987) Chemotactic activity of lens proteins and the pathogenesis of phacolytic glaucoma. Arch Ophthalmol 105:1582\u20131584","journal-title":"Arch Ophthalmol"},{"key":"396_CR67","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1001\/archopht.1958.00940080848004","volume":"60","author":"PA Chandler","year":"1958","unstructured":"Chandler PA (1958) Problems in the diagnosis and treatment of lens-induced uveitis and glaucoma. AMA Arch Ophthalmol 60:828\u2013841","journal-title":"AMA Arch Ophthalmol"},{"key":"396_CR68","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0039-6257(92)90109-7","volume":"36","author":"GE Marak Jr","year":"1992","unstructured":"Marak GE Jr (1992) Phacoanaphylactic endophthalmitis. Surv Ophthalmol 36:325\u2013339","journal-title":"Surv Ophthalmol"},{"key":"396_CR69","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0161-6420(89)32939-3","volume":"96","author":"DM Meisler","year":"1989","unstructured":"Meisler DM, Mandelbaum S (1989) Propionibacterium-associated endophthalmitis after extracapsular cataract extraction. Review of reported cases. Ophthalmology 96:54\u201361","journal-title":"Ophthalmology"},{"key":"396_CR70","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ophtha.2016.12.010","volume":"124","author":"T Oshika","year":"2017","unstructured":"Oshika T, Eguchi S, Goto H, Ohashi Y (2017) Outbreak of subacute-onset toxic anterior segment syndrome associated with single-piece acrylic intraocular lenses. Ophthalmology 124:519\u2013523","journal-title":"Ophthalmology"},{"key":"396_CR71","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jcrs.2006.01.065","volume":"32","author":"N Mamalis","year":"2006","unstructured":"Mamalis N et al (2006) Toxic anterior segment syndrome. J Cataract Refractive Surg 32:324\u2013333","journal-title":"J Cataract Refractive Surg"},{"key":"396_CR72","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.jcrs.2012.06.053","volume":"38","author":"Z Bodnar","year":"2012","unstructured":"Bodnar Z, Clouser S, Mamalis N (2012) Toxic anterior segment syndrome: update on the most common causes. J Cataract Refractive Surg 38:1902\u20131910","journal-title":"J Cataract Refractive Surg"},{"key":"396_CR73","unstructured":"Ophthalmology, A.A.o. Differential Diagnosis. (2020)"},{"key":"396_CR74","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0002-9343(75)90390-3","volume":"59","author":"RS Dobrin","year":"1975","unstructured":"Dobrin RS, Vernier RL, Fish AL (1975) Acute eosinophilic interstitial nephritis and renal failure with bone marrow-lymph node granulomas and anterior uveitis. A new syndrome. Am J Med 59:325\u2013333","journal-title":"Am J Med"},{"key":"396_CR75","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/ndt\/gfab030","volume":"37","author":"A Regusci","year":"2022","unstructured":"Regusci A et al (2022) Tubulointerstitial nephritis and uveitis syndrome: a systematic review. Nephrol Dial Transplant 37:876\u2013886","journal-title":"Nephrol Dial Transplant"},{"key":"396_CR76","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0039-6257(01)00261-2","volume":"46","author":"JT Mandeville","year":"2001","unstructured":"Mandeville JT, Levinson RD, Holland GN (2001) The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 46:195\u2013208","journal-title":"Surv Ophthalmol"},{"key":"396_CR77","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13023-017-0677-2","volume":"12","author":"LO Okafor","year":"2017","unstructured":"Okafor LO, Hewins P, Murray PI, Denniston AK (2017) Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, demographics and risk factors. Orphanet J Rare Dis 12:128","journal-title":"Orphanet J Rare Dis"},{"key":"396_CR78","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/09273948.2015.1034374","volume":"24","author":"MC Aguilar","year":"2016","unstructured":"Aguilar MC, Lonngi M, de-la-Torre A (2016) Tubulointerstitial nephritis and uveitis syndrome: case report and review of the literature. Ocul Immunol Inflamm 24:415\u2013421","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR79","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ajoc.2018.03.006","volume":"10","author":"S Caplash","year":"2018","unstructured":"Caplash S et al (2018) Treatment challenges in an atypical presentation of tubulointerstitial nephritis and uveitis (TINU). Am J Ophthalmol Case Rep 10:253\u2013256","journal-title":"Am J Ophthalmol Case Rep"},{"key":"396_CR80","unstructured":"Kong CL, B.B., Loewen R, Conner E, Zambrano EV, Khatib L, Errera MH (2022) Case report: severe atypical presentation of uveitis associated with tubulointerstitial nephritis. J Ophthalmol Res"},{"key":"396_CR81","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ajo.2021.03.041","volume":"228","author":"Standardization of Uveitis Nomenclature Working, G","year":"2021","unstructured":"Standardization of Uveitis Nomenclature Working, G (2021) Classification criteria for tubulointerstitial nephritis with uveitis syndrome. Am J Ophthalmol 228:255\u2013261","journal-title":"Am J Ophthalmol"},{"key":"396_CR82","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.ophtha.2007.01.002","volume":"114","author":"F Mackensen","year":"2007","unstructured":"Mackensen F, Smith JR, Rosenbaum JT (2007) Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology 114:995\u2013999","journal-title":"Ophthalmology"},{"key":"396_CR83","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/ICU.0b013e3283318f9a","volume":"20","author":"F Mackensen","year":"2009","unstructured":"Mackensen F, Billing H (2009) Tubulointerstitial nephritis and uveitis syndrome. Curr Opin Ophthalmol 20:525\u2013531","journal-title":"Curr Opin Ophthalmol"},{"key":"396_CR84","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/IIO.0b013e31817d8455","volume":"48","author":"RD Levinson","year":"2008","unstructured":"Levinson RD (2008) Tubulointerstitial nephritis and uveitis syndrome. Int Ophthalmol Clin 48:51\u201359","journal-title":"Int Ophthalmol Clin"},{"key":"396_CR85","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/ICU.0000000000000421","volume":"28","author":"K Pakzad-Vaezi","year":"2017","unstructured":"Pakzad-Vaezi K, Pepple KL (2017) Tubulointerstitial nephritis and uveitis. Curr Opin Ophthalmol 28:629\u2013635","journal-title":"Curr Opin Ophthalmol"},{"key":"396_CR86","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.ophtha.2006.07.065","volume":"114","author":"DA Jabs","year":"2007","unstructured":"Jabs DA et al (2007) Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology 114:787\u2013793","journal-title":"Ophthalmology"},{"key":"396_CR87","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/09273948.2017.1394471","volume":"26","author":"NS Chan","year":"2018","unstructured":"Chan NS, Chee SP, Caspers L, Bodaghi B (2018) Clinical Features of CMV-Associated Anterior Uveitis. Ocul Immunol Inflamm 26:107\u2013115","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR88","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajo.2007.12.015","volume":"145","author":"SP Chee","year":"2008","unstructured":"Chee SP et al (2008) Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol 145:834\u2013840","journal-title":"Am J Ophthalmol"},{"key":"396_CR89","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.ajo.2008.09.001","volume":"146","author":"SP Chee","year":"2008","unstructured":"Chee SP, Jap A (2008) Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol 146:883\u2013889 e881","journal-title":"Am J Ophthalmol"},{"key":"396_CR90","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/bjophthalmol-2013-304625","volume":"99","author":"N Koizumi","year":"2015","unstructured":"Koizumi N et al (2015) Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study. Br J Ophthalmol 99:54\u201358","journal-title":"Br J Ophthalmol"},{"key":"396_CR91","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1167\/iovs.18-24597","volume":"60","author":"S Touhami","year":"2019","unstructured":"Touhami S et al (2019) Predictive factors of intraocular pressure level evolution over time and glaucoma severity in fuchs\u2019 heterochromic iridocyclitis. Invest Ophthalmol Vis Sci 60:2399\u20132405","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"396_CR92","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ajo.2005.07.078","volume":"141","author":"JD de Groot-Mijnes","year":"2006","unstructured":"de Groot-Mijnes JD et al (2006) Rubella virus is associated with fuchs heterochromic iridocyclitis. Am J Ophthalmol 141:212\u2013214","journal-title":"Am J Ophthalmol"},{"key":"396_CR93","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ajo.2004.02.055","volume":"138","author":"CD Quentin","year":"2004","unstructured":"Quentin CD, Reiber H (2004) Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol 138:46\u201354","journal-title":"Am J Ophthalmol"},{"key":"396_CR94","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/09273948.2019.1662059","volume":"29","author":"I Leleu","year":"2021","unstructured":"Leleu I et al (2021) Clinical features and diagnosis of anterior segment inflammation related to cytomegalovirus in immunocompetent African, Asian, and caucasian patients. Ocul Immunol Inflamm 29:160\u2013168","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR95","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.ophtha.2006.09.035","volume":"114","author":"LA van Boxtel","year":"2007","unstructured":"van Boxtel LA, van der Lelij A, van der Meer J, Los LI (2007) Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology 114:1358\u20131362","journal-title":"Ophthalmology"},{"key":"396_CR96","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1007\/s10792-019-01125-5","volume":"39","author":"JI Sakai","year":"2019","unstructured":"Sakai JI, Usui Y, Suzuki J, Kezuka T, Goto H (2019) Clinical features of anterior uveitis caused by three different herpes viruses. Int Ophthalmol 39:2785\u20132795","journal-title":"Int Ophthalmol"},{"key":"396_CR97","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajo.2021.03.020","volume":"227","author":"Y Terada","year":"2021","unstructured":"Terada Y et al (2021) Distinguishing features of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Am J Ophthalmol 227:191\u2013200","journal-title":"Am J Ophthalmol"},{"key":"396_CR98","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10384-014-0340-6","volume":"58","author":"H Takase","year":"2014","unstructured":"Takase H et al (2014) Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Jpn J Ophthalmol 58:473\u2013482","journal-title":"Jpn J Ophthalmol"},{"key":"396_CR99","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00005792-200107000-00005","volume":"80","author":"B Bodaghi","year":"2001","unstructured":"Bodaghi B et al (2001) Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore) 80:263\u2013270","journal-title":"Medicine (Baltimore)"},{"key":"396_CR100","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2147\/OPTH.S80972","volume":"9","author":"A Bajwa","year":"2015","unstructured":"Bajwa A et al (2015) Epidemiology of uveitis in the mid-Atlantic United States. Clin Ophthalmol 9:889\u2013901","journal-title":"Clin Ophthalmol"},{"key":"396_CR101","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3109\/08820538.2016.1170158","volume":"32","author":"EM D'Ambrosio","year":"2017","unstructured":"D\u2019Ambrosio EM et al (2017) Clinical features and complications of the HLA-B27-associated acute anterior uveitis: a metanalysis. Seminars Ophthalmol 32:689\u2013701","journal-title":"Seminars Ophthalmol"},{"key":"396_CR102","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3109\/09273948.2016.1158283","volume":"24","author":"D Wakefield","year":"2016","unstructured":"Wakefield D, Yates W, Amjadi S, McCluskey P (2016) HLA-B27 Anterior Uveitis: Immunology and Immunopathology. Ocul Immunol Inflamm 24:450\u2013459","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR103","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0039-6257(91)90005-Z","volume":"36","author":"D Wakefield","year":"1991","unstructured":"Wakefield D, Montanaro A, McCluskey P (1991) Acute anterior uveitis and HLA-B27. Surv Ophthalmol 36:223\u2013232","journal-title":"Surv Ophthalmol"},{"key":"396_CR104","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/09273948.2016.1185527","volume":"25","author":"K Pathanapitoon","year":"2017","unstructured":"Pathanapitoon K, Dodds EM, Cunningham ET Jr, Rothova A (2017) Clinical Spectrum of HLA-B27-associated Ocular Inflammation. Ocul Immunol Inflamm 25:569\u2013576","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR105","first-page":"489813","volume":"2015","author":"A Yoshida","year":"2015","unstructured":"Yoshida A, Obata H, Kawashima H (2015) Cytomegalovirus uveitis with hypopyon mimicking bacterial endophthalmitis. Case Rep Ophthalmological Med 2015:489813","journal-title":"Case Rep Ophthalmological Med"},{"key":"396_CR106","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/09273948.2016.1234626","volume":"26","author":"PS Ganapathy","year":"2018","unstructured":"Ganapathy PS, Lowder CY, Srivastava SK (2018) Aggressive initial presentation of HLA-B27 uveitis in older individuals: a case series. Ocul Immunol Inflamm 26:425\u2013427","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR107","doi-asserted-by":"publisher","first-page":"100589","DOI":"10.1016\/j.ajoc.2020.100589","volume":"17","author":"ZH Toh","year":"2020","unstructured":"Toh ZH, Agrawal R (2020) Diagnostic dilemma: unilateral panuveitis mimicking endophthalmitis in very severe HLA B27-associated uveitis. Am J Ophthalmol Case Rep 17:100589","journal-title":"Am J Ophthalmol Case Rep"},{"key":"396_CR108","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/ICU.0000000000000326","volume":"28","author":"P Garg","year":"2017","unstructured":"Garg P, Roy A, Sharma S (2017) Endophthalmitis after cataract surgery: epidemiology, risk factors, and evidence on protection. Curr Opin Ophthalmol 28:67\u201372","journal-title":"Curr Opin Ophthalmol"},{"key":"396_CR109","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1128\/CMR.00113-16","volume":"30","author":"ML Durand","year":"2017","unstructured":"Durand ML (2017) Bacterial and fungal endophthalmitis. Clin Microbiol Rev 30:597\u2013613","journal-title":"Clin Microbiol Rev"},{"key":"396_CR110","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/S0161-6420(13)31255-X","volume":"101","author":"AA Okada","year":"1994","unstructured":"Okada AA, Johnson RP, Liles WC, D\u2019Amico DJ, Baker AS (1994) Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology 101:832\u2013838","journal-title":"Ophthalmology"},{"key":"396_CR111","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/09273948.2019.1642497","volume":"28","author":"TL Jenkins","year":"2020","unstructured":"Jenkins TL et al (2020) Endogenous bacterial endophthalmitis: a five-year retrospective review at a tertiary care academic center. Ocul Immunol Inflamm 28:975\u2013983","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR112","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/eye.2010.145","volume":"25","author":"PP Connell","year":"2011","unstructured":"Connell PP et al (2011) Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye (Lond) 25:66\u201372","journal-title":"Eye (Lond)"},{"key":"396_CR113","first-page":"496","volume":"26","author":"H Cho","year":"2018","unstructured":"Cho H et al (2018) Endogenous endophthalmitis in the American and Korean population: an 8-year retrospective study. Ocul Immunol Inflamm 26:496\u2013503","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR114","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.survophthal.2014.06.002","volume":"59","author":"TL Jackson","year":"2014","unstructured":"Jackson TL, Paraskevopoulos T, Georgalas I (2014) Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol 59:627\u2013635","journal-title":"Surv Ophthalmol"},{"key":"396_CR115","first-page":"508","volume":"26","author":"MF Chersich","year":"2018","unstructured":"Chersich MF et al (2018) Diagnosis and treatment of listeria monocytogenes endophthalmitis: a systematic review. Ocul Immunol Inflamm 26:508\u2013517","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR116","first-page":"527","volume":"26","author":"SD Dadia","year":"2018","unstructured":"Dadia SD et al (2018) Salmonella typhi associated endogenous endophthalmitis: a case report and a review of literature. Ocul Immunol Inflamm 26:527\u2013532","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR117","first-page":"533","volume":"26","author":"S Silpa-Archa","year":"2018","unstructured":"Silpa-Archa S, Ponwong A, Preble JM, Foster CS (2018) Culture-positive endogenous endophthalmitis: an eleven-year retrospective study in the Central Region of Thailand. Ocul Immunol Inflamm 26:533\u2013542","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR118","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0039-6257(98)00036-8","volume":"43","author":"MS Kresloff","year":"1998","unstructured":"Kresloff MS, Castellarin AA, Zarbin MA (1998) Endophthalmitis. Surv Ophthalmol 43:193\u2013224","journal-title":"Surv Ophthalmol"},{"key":"396_CR119","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","volume":"113","author":"Results of the Endophthalmitis Vitrectomy Study","year":"1995","unstructured":"Results of the Endophthalmitis Vitrectomy Study (1995) A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis vitrectomy study group. Arch Ophthalmol 113:1479\u20131496","journal-title":"Arch Ophthalmol"},{"key":"396_CR120","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3109\/08820538.2013.877939","volume":"30","author":"G Gokce","year":"2015","unstructured":"Gokce G, Sobaci G, Ozgonul C (2015) Post-traumatic endophthalmitis: a mini-review. Sem Ophthalmol 30:470\u2013474","journal-title":"Sem Ophthalmol"},{"key":"396_CR121","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/eye.2010.17","volume":"24","author":"N Saliba","year":"2010","unstructured":"Saliba N, Owen ME, Beare N (2010) Tattoo-associated uveitis. Eye (Lond) 24:1406","journal-title":"Eye (Lond)"},{"key":"396_CR122","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1001\/jamaophthalmol.2015.3354","volume":"133","author":"AK Reddy","year":"2015","unstructured":"Reddy AK, Shildkrot Y, Newman SA, Thorne JE (2015) T-Lymphocyte predominance and cellular atypia in tattoo-associated uveitis. JAMA Ophthalmol 133:1356\u20131357","journal-title":"JAMA Ophthalmol"},{"key":"396_CR123","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.ajo.2014.09.006","volume":"158","author":"VB Pandya","year":"2014","unstructured":"Pandya VB, Hooper CY, Essex RW, Cook M (2014) Tattoo-associated uveitis. Am J Ophthalmol 158:1355\u20131356","journal-title":"Am J Ophthalmol"},{"key":"396_CR124","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ajo.2014.05.019","volume":"158","author":"TA Ostheimer","year":"2014","unstructured":"Ostheimer TA et al (2014) Tattoo-associated uveitis. Am J Ophthalmol 158:637\u2013643 e631","journal-title":"Am J Ophthalmol"},{"key":"396_CR125","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ajo.2014.11.017","volume":"159","author":"AM Mansour","year":"2015","unstructured":"Mansour AM, Chan CC (2015) Tattoo-associated uveitis. Am J Ophthalmol 159:408\u2013409","journal-title":"Am J Ophthalmol"},{"key":"396_CR126","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1111\/jdv.15070","volume":"32","author":"N Kluger","year":"2018","unstructured":"Kluger N (2018) Tattoo-associated uveitis with or without systemic sarcoidosis: a comparative review of the literature. J Eur Acad Dermatol Venereol 32:1852\u20131861","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"396_CR127","doi-asserted-by":"publisher","first-page":"e144543","DOI":"10.1001\/jamaophthalmol.2014.4543","volume":"133","author":"MK Adam","year":"2015","unstructured":"Adam MK, Rahimy E, Dunn JP (2015) Tattoo-associated uveitis. JAMA Ophthalmol 133:e144543","journal-title":"JAMA Ophthalmol"},{"key":"396_CR128","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/ICB.0000000000000342","volume":"11","author":"VB Pandya","year":"2017","unstructured":"Pandya VB, Hooper CY, Merani R, McCluskey P (2017) Tattoo-associated uveitis with choroidal granuloma: a rare presentation of systemic sarcoidosis. Retinal Cases Brief Rep 11:272\u2013276","journal-title":"Retinal Cases Brief Rep"},{"key":"396_CR129","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/01.icu.0000434534.32063.5c","volume":"24","author":"RS Moorthy","year":"2013","unstructured":"Moorthy RS, London NJ, Garg SJ, Cunningham ET Jr (2013) Drug-induced uveitis. Curr Opin Ophthalmol 24:589\u2013597","journal-title":"Curr Opin Ophthalmol"},{"key":"396_CR130","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.ophtha.2011.02.038","volume":"118","author":"PA Campochiaro","year":"2011","unstructured":"Campochiaro PA et al (2011) Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology 118:2041\u20132049","journal-title":"Ophthalmology"},{"key":"396_CR131","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","volume":"116","author":"DM Brown","year":"2009","unstructured":"Brown DM et al (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology 116:57\u201365 e55","journal-title":"Ophthalmology"},{"key":"396_CR132","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1016\/j.ophtha.2020.01.029","volume":"127","author":"Comparison of Age-related Macular Degeneration Treatments Trials Research, G","year":"2020","unstructured":"Comparison of Age-related Macular Degeneration Treatments Trials Research, G et al (2020) Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration. Ophthalmology 127:S135\u2013S145","journal-title":"Ophthalmology"},{"key":"396_CR133","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ajo.2007.10.004","volume":"145","author":"CD Regillo","year":"2008","unstructured":"Regillo CD et al (2008) Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol 145:239\u2013248","journal-title":"Am J Ophthalmol"},{"key":"396_CR134","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.ophtha.2011.02.022","volume":"118","author":"DM Brown","year":"2011","unstructured":"Brown DM et al (2011) Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 118:1594\u20131602","journal-title":"Ophthalmology"},{"key":"396_CR135","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.ophtha.2008.05.007","volume":"115","author":"SS Wickremasinghe","year":"2008","unstructured":"Wickremasinghe SS et al (2008) Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration. Ophthalmology 115:1911\u20131915","journal-title":"Ophthalmology"},{"key":"396_CR136","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/ICU.0000000000000849","volume":"33","author":"BL Kuo","year":"2022","unstructured":"Kuo BL, Singh RP (2022) Brolucizumab for the treatment of diabetic macular edema. Curr Opin Ophthalmol 33:167\u2013173","journal-title":"Curr Opin Ophthalmol"},{"key":"396_CR137","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ajo.2022.01.004","volume":"238","author":"DM Brown","year":"2022","unstructured":"Brown DM et al (2022) KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema. Am J Ophthalmol 238:157\u2013172","journal-title":"Am J Ophthalmol"},{"key":"396_CR138","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.3390\/biomedicines11061548","volume":"11","author":"M Biarnes","year":"2023","unstructured":"Biarnes M et al (2023) Methodological appraisal of phase 3 clinical trials in geographic atrophy. Biomedicines 11:1548","journal-title":"Biomedicines"},{"key":"396_CR139","unstructured":"Beovu\u00ae [US prescribing information]. (ed. Novartis) ( East Hanover, NJ (2019))"},{"key":"396_CR140","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.oret.2021.05.003","volume":"6","author":"M Singer","year":"2022","unstructured":"Singer M et al (2022) Clinical characteristics and outcomes of eyes with intraocular inflammation after brolucizumab: post hoc analysis of HAWK and HARRIER. Ophthalmol Retina 6:97\u2013108","journal-title":"Ophthalmol Retina"},{"key":"396_CR141","doi-asserted-by":"publisher","first-page":"100989","DOI":"10.1016\/j.ajoc.2020.100989","volume":"20","author":"PG Iyer","year":"2020","unstructured":"Iyer PG et al (2020) Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: a clinicopathologic case study. Am J Ophthalmol Case Rep 20:100989","journal-title":"Am J Ophthalmol Case Rep"},{"key":"396_CR142","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","volume":"127","author":"PU Dugel","year":"2020","unstructured":"Dugel PU et al (2020) HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology 127:72\u201384","journal-title":"Ophthalmology"},{"key":"396_CR143","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40942-021-00307-7","volume":"7","author":"WJ Anderson","year":"2021","unstructured":"Anderson WJ et al (2021) Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review. Int J Retina Vitreous 7:37","journal-title":"Int J Retina Vitreous"},{"key":"396_CR144","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0002-9394(98)00071-3","volume":"126","author":"RD Fechtner","year":"1998","unstructured":"Fechtner RD et al (1998) Anterior uveitis associated with latanoprost. Am J Ophthalmol 126:37\u201341","journal-title":"Am J Ophthalmol"},{"key":"396_CR145","doi-asserted-by":"crossref","unstructured":"Li D, Yang L, Bai F, Zeng S, Liu X (2022) Clinical manifestations, diagnosis, treatment and prognosis of uveitis induced by anticancer drugs: a review of literature. Brain Sci 12","DOI":"10.3390\/brainsci12091168"},{"key":"396_CR146","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ejca.2020.11.027","volume":"144","author":"F Dimitriou","year":"2021","unstructured":"Dimitriou F et al (2021) The association between immune checkpoint or BRAF\/MEK inhibitor therapy and uveitis in patients with advanced cutaneous melanoma. Eur J Cancer 144:215\u2013223","journal-title":"Eur J Cancer"},{"key":"396_CR147","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ajo.2014.07.003","volume":"158","author":"CH Choe","year":"2014","unstructured":"Choe CH, McArthur GA, Caro I, Kempen JH, Amaravadi RK (2014) Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib. Am J Ophthalmol 158:831\u2013837 e832","journal-title":"Am J Ophthalmol"},{"key":"396_CR148","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajoc.2016.09.003","volume":"6","author":"KA Klein","year":"2017","unstructured":"Klein KA, Azzoli CG, Rifkin LM (2017) Bilateral acute simultaneous onset anterior uveitis presumed secondary to erlotinib: a report of two cases. Am J Ophthalmol Case Rep 6:21\u201323","journal-title":"Am J Ophthalmol Case Rep"},{"key":"396_CR149","doi-asserted-by":"crossref","unstructured":"Chan S, Ahern E, Chaudhry S, Hughes B (2019) Bilateral acute anterior uveitis: a rare ocular side effect of erlotinib. BMJ Case Rep 12","DOI":"10.1136\/bcr-2019-232868"},{"key":"396_CR150","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000448730","volume":"7","author":"H Kiratli","year":"2016","unstructured":"Kiratli H, Mocan MC, Irkec M (2016) In vivo confocal microscopy in differentiating ipilimumab-induced anterior uveitis from metastatic uveal melanoma. Case Rep Ophthalmol 7:126\u2013131","journal-title":"Case Rep Ophthalmol"},{"key":"396_CR151","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/09273948.2019.1577978","volume":"28","author":"P Sun Mm Md","year":"2020","unstructured":"Sun Mm Md P et al (2020) Uveitis in patients treated with CTLA-4 and PD-1 checkpoint blockade inhibition. Ocul Immunol Inflamm 28:217\u2013227","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR152","first-page":"140","volume":"24","author":"E Papavasileiou","year":"2016","unstructured":"Papavasileiou E, Prasad S, Freitag SK, Sobrin L, Lobo AM (2016) Ipilimumab-induced ocular and orbital inflammation\u2013a case series and review of the literature. Ocul Immunol Inflamm 24:140\u2013146","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR153","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/bjophthalmol-2019-314403","volume":"104","author":"AG Venkat","year":"2020","unstructured":"Venkat AG et al (2020) Local therapy for cancer therapy-associated uveitis: a case series and review of the literature. Br J Ophthalmol 104:703\u2013711","journal-title":"Br J Ophthalmol"},{"key":"396_CR154","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1038\/eye.2009.234","volume":"23","author":"M Wefers Bettink-Remeijer","year":"2009","unstructured":"Wefers Bettink-Remeijer M et al (2009) Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye (Lond) 23:2260\u20132262","journal-title":"Eye (Lond)"},{"key":"396_CR155","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/eye.2010.19","volume":"24","author":"F Willermain","year":"2010","unstructured":"Willermain F et al (2010) Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye (Lond) 24:1419 author reply 1419-1420","journal-title":"Eye (Lond)"},{"key":"396_CR156","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2165\/00003088-200039030-00003","volume":"39","author":"JI Kuper","year":"2000","unstructured":"Kuper JI, D\u2019Aprile M (2000) Drug-Drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease. Clin Pharmacokinet 39:203\u2013214","journal-title":"Clin Pharmacokinet"},{"key":"396_CR157","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2165\/00003088-199528020-00003","volume":"28","author":"MH Skinner","year":"1995","unstructured":"Skinner MH, Blaschke TF (1995) Clinical pharmacokinetics of rifabutin. Clin Pharmacokinet 28:115\u2013125","journal-title":"Clin Pharmacokinet"},{"key":"396_CR158","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1086\/517366","volume":"177","author":"SD Shafran","year":"1998","unstructured":"Shafran SD et al (1998) Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study Group. J Infect Dis 177:252\u2013255","journal-title":"J Infect Dis"},{"key":"396_CR159","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1002\/art.22918","volume":"56","author":"LL Lim","year":"2007","unstructured":"Lim LL, Fraunfelder FW, Rosenbaum JT (2007) Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum 56:3248\u20133252","journal-title":"Arthritis Rheum"},{"key":"396_CR160","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s00417-020-04777-7","volume":"258","author":"B Bostanci Ceran","year":"2020","unstructured":"Bostanci Ceran B, Ozates S (2020) Ocular manifestations of coronavirus disease 2019. Graefes Arch Clin Exp Ophthalmol 258:1959\u20131963","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"396_CR161","unstructured":"United States Department of Health and Human Services (DHHS) (Vaccine Adverse Event Reporting System). (2022)"},{"key":"396_CR162","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12348-021-00275-x","volume":"12","author":"I Testi","year":"2022","unstructured":"Testi I, Brandao-de-Resende C, Agrawal R, Pavesio C, Group, C.-V.O.I.E.S. (2022) Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect 12:4","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"396_CR163","doi-asserted-by":"crossref","unstructured":"Haseeb AA, Solyman O, Abushanab MM, Abo Obaia AS, Elhusseiny AM (2022) Ocular complications following vaccination for COVID-19: a one-year retrospective. Vaccines (Basel) 10","DOI":"10.3390\/vaccines10020342"},{"key":"396_CR164","doi-asserted-by":"crossref","unstructured":"Bolletta E\u00a0et al (2021)\u00a0Uveitis and other ocular complications following COVID-19 vaccination. J Clin Med 10","DOI":"10.3390\/jcm10245960"},{"key":"396_CR165","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12348-022-00298-y","volume":"12","author":"S Murgova","year":"2022","unstructured":"Murgova S, Balchev G (2022) Ophthalmic manifestation after SARS-CoV-2 vaccination: a case series. J Ophthalmic Inflamm Infect 12:20","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"396_CR166","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13256-022-03350-6","volume":"16","author":"JM Ortiz-Egea","year":"2022","unstructured":"Ortiz-Egea JM, Sanchez CG, Lopez-Jimenez A, Navarro OD (2022) Herpetic anterior uveitis following Pfizer-BioNTech coronavirus disease 2019 vaccine: two case reports. J Med Case Rep 16:127","journal-title":"J Med Case Rep"},{"key":"396_CR167","doi-asserted-by":"crossref","unstructured":"Arora A et al (2022) Recurrence of tubercular choroiditis following anti-SARS-CoV-2 vaccination. Eur J Ophthalmol 11206721221088439","DOI":"10.1177\/11206721221088439"},{"key":"396_CR168","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/09273948.2021.1957123","volume":"29","author":"M Goyal","year":"2021","unstructured":"Goyal M, Murthy SI, Annum S (2021) Bilateral Multifocal Choroiditis following COVID-19 Vaccination. Ocul Immunol Inflamm 29:753\u2013757","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR169","doi-asserted-by":"crossref","unstructured":"Mishra SB, Mahendradas P, Kawali A, Sanjay S, Shetty R (2021) Reactivation of varicella zoster infection presenting as acute retinal necrosis post COVID 19 vaccination in an Asian Indian male. Eur J Ophthalmol 11206721211046485","DOI":"10.1177\/11206721211046485"},{"key":"396_CR170","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1097\/IAE.0000000000003277","volume":"41","author":"T Rabinovitch","year":"2021","unstructured":"Rabinovitch T et al (2021) UVEITIS AFTER THE BNT162b2 mRNA VACCINATION AGAINST SARS-CoV-2 INFECTION: A Possible Association. Retina 41:2462\u20132471","journal-title":"Retina"},{"key":"396_CR171","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12348-021-00262-2","volume":"11","author":"CP Herbort Jr","year":"2021","unstructured":"Herbort CP Jr, Papasavvas I (2021) Effect of SARS-CoV-2 mRNA vaccination on ocular herpes simplex and varicella-zoster virus reactivation: should preventive antiviral treatment be given in known herpes patients. J Ophthalmic Inflamm Infect 11:33","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"396_CR172","doi-asserted-by":"crossref","unstructured":"Balidis M et al (2021) Acute corneal graft rejection after anti-severe acute respiratory syndrome-coronavirus-2 vaccination: a report of four cases. Eur J Ophthalmol 11206721211064033","DOI":"10.1177\/11206721211064033"},{"key":"396_CR173","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.4103\/ijo.IJO_2515_21","volume":"69","author":"DP Parmar","year":"2021","unstructured":"Parmar DP, Garde PV, Shah SM, Bhole PK (2021) Acute graft rejection in a high-risk corneal transplant following COVID-19 vaccination: a case report. Indian J Ophthalmol 69:3757\u20133758","journal-title":"Indian J Ophthalmol"},{"key":"396_CR174","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/j.jfo.2021.06.001","volume":"44","author":"A Crnej","year":"2021","unstructured":"Crnej A, Khoueir Z, Cherfan G, Saad A (2021) Acute corneal endothelial graft rejection following COVID-19 vaccination. J Fr Ophtalmol 44:e445\u2013e447","journal-title":"J Fr Ophtalmol"},{"key":"396_CR175","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41433-021-01671-2","volume":"36","author":"KI Rallis","year":"2022","unstructured":"Rallis KI, Ting DSJ, Said DG, Dua HS (2022) Corneal graft rejection following COVID-19 vaccine. Eye (Lond) 36:1319\u20131320","journal-title":"Eye (Lond)"},{"key":"396_CR176","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/ICO.0000000000002761","volume":"40","author":"LM Wasser","year":"2021","unstructured":"Wasser LM, Roditi E, Zadok D, Berkowitz L, Weill Y (2021) Keratoplasty rejection after the BNT162b2 messenger RNA vaccine. Cornea 40:1070\u20131072","journal-title":"Cornea"},{"key":"396_CR177","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jtos.2021.09.007","volume":"23","author":"S Singh","year":"2022","unstructured":"Singh S et al (2022) SARS-CoV-2 and its beta variant of concern infect human conjunctival epithelial cells and induce differential antiviral innate immune response. Ocul Surf 23:184\u2013194","journal-title":"Ocul Surf"},{"key":"396_CR178","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/bjophthalmol-2021-319338","volume":"105","author":"M Phylactou","year":"2021","unstructured":"Phylactou M, Li JO, Larkin DFP (2021) Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine. Br J Ophthalmol 105:893\u2013896","journal-title":"Br J Ophthalmol"},{"key":"396_CR179","doi-asserted-by":"crossref","unstructured":"Fujio K et al (2022) Characteristics and clinical ocular manifestations in patients with acute corneal graft rejection after receiving the COVID-19 vaccine: a systematic review. J Clin Med 11","DOI":"10.3390\/jcm11154500"},{"key":"396_CR180","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/archopht.120.1.15","volume":"120","author":"M Sainz de la Maza","year":"2002","unstructured":"Sainz de la Maza M, Foster CS, Jabbur NS, Baltatzis S (2002) Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol 120:15\u201319","journal-title":"Arch Ophthalmol"},{"key":"396_CR181","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0161-6420(94)31325-X","volume":"101","author":"M Sainz de la Maza","year":"1994","unstructured":"Sainz de la Maza M, Jabbur NS, Foster CS (1994) Severity of scleritis and episcleritis. Ophthalmology 101:389\u2013396","journal-title":"Ophthalmology"},{"key":"396_CR182","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.rdc.2007.08.002","volume":"33","author":"A Galor","year":"2007","unstructured":"Galor A, Thorne JE (2007) Scleritis and peripheral ulcerative keratitis. Rheumatic Dis Clin North Am 33:835\u2013854, vii","journal-title":"Rheumatic Dis Clin North Am"},{"key":"396_CR183","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.ophtha.2003.12.052","volume":"111","author":"FW Fraunfelder","year":"2004","unstructured":"Fraunfelder FW, Fraunfelder FT (2004) Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects. Ophthalmology 111:1275\u20131279","journal-title":"Ophthalmology"},{"key":"396_CR184","first-page":"91","volume":"134","author":"LE Wolpert","year":"2021","unstructured":"Wolpert LE, Watts AR (2021) Zoledronate-induced anterior uveitis, scleritis and optic neuritis: a case report. N Z Med J 134:91\u201394","journal-title":"N Z Med J"},{"key":"396_CR185","doi-asserted-by":"publisher","first-page":"370","DOI":"10.5694\/j.1326-5377.2008.tb01658.x","volume":"188","author":"MM Moore","year":"2008","unstructured":"Moore MM, Beith JM (2008) Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer. Med J Aust 188:370\u2013371","journal-title":"Med J Aust"},{"key":"396_CR186","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/09273940802056281","volume":"16","author":"KF Tabbara","year":"2008","unstructured":"Tabbara KF (2008) Nodular scleritis following alendronate therapy. Ocul Immunol Inflamm 16:99\u2013101","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR187","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/01.SMJ.0000152753.80490.9F","volume":"98","author":"S Leung","year":"2005","unstructured":"Leung S, Ashar BH, Miller RG (2005) Bisphosphonate-associated scleritis: a case report and review. South Med J 98:733\u2013735","journal-title":"South Med J"},{"key":"396_CR188","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ophtha.2020.09.041","volume":"128","author":"C Provost","year":"2021","unstructured":"Provost C, Sene T, Lecler A (2021) Bisphosphonate-induced posterior scleritis. Ophthalmology 128:371","journal-title":"Ophthalmology"},{"key":"396_CR189","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/09273940591004133","volume":"13","author":"C Kafkala","year":"2005","unstructured":"Kafkala C, Daoud YJ, Paredes I, Foster CS (2005) Masquerade scleritis. Ocul Immunol Inflamm 13:479\u2013482","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR190","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/IOP.0000000000000720","volume":"33","author":"M Sharma","year":"2017","unstructured":"Sharma M et al (2017) Invasive Ocular Surface Squamous Neoplasia Masquerading as Nodular Scleritis. Ophthalmic Plast Reconstr Surg 33:e45\u2013e47","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"396_CR191","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.4103\/ijo.IJO_271_20","volume":"68","author":"CA Putri","year":"2020","unstructured":"Putri CA, Salvi SM (2020) Necrotic choroidal melanoma masquerading as scleritis. Indian J Ophthalmol 68:1979\u20131981","journal-title":"Indian J Ophthalmol"},{"key":"396_CR192","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0046-8177(90)90181-4","volume":"21","author":"DM Knowles","year":"1990","unstructured":"Knowles DM, Jakobiec FA, McNally L, Burke JS (1990) Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol 21:959\u2013973","journal-title":"Hum Pathol"},{"key":"396_CR193","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3928\/01913913-20201221-03","volume":"58","author":"M Pattnaik","year":"2021","unstructured":"Pattnaik M, Tripathy D, Mittal R (2021) Subconjunctival dirofilariasis mimicking infectious scleritis. J Pediatr Ophthalmol Strabismus 58:136","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"396_CR194","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.4269\/ajtmh.21-0186","volume":"105","author":"M Hasanreisoglu","year":"2021","unstructured":"Hasanreisoglu M et al (2021) Case report: a human case of onchocerca lupi mimicking nodular scleritis. Am J Trop Med Hyg 105:1782\u20131785","journal-title":"Am J Trop Med Hyg"},{"key":"396_CR195","doi-asserted-by":"publisher","first-page":"101465","DOI":"10.1016\/j.ajoc.2022.101465","volume":"26","author":"JL Chen","year":"2022","unstructured":"Chen JL, Men M, Naini BV, Tsui E (2022) IgG4-related hypertensive granulomatous anterior uveitis. Am J Ophthalmol Case Rep 26:101465","journal-title":"Am J Ophthalmol Case Rep"},{"key":"396_CR196","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/09273948.2014.985384","volume":"23","author":"E Philippakis","year":"2015","unstructured":"Philippakis E et al (2015) IgG4-related disease masquerading as recurrent scleritis and chronic conjunctivitis. Ocul Immunol Inflamm 23:168\u2013172","journal-title":"Ocul Immunol Inflamm"},{"key":"396_CR197","doi-asserted-by":"publisher","first-page":"e29611","DOI":"10.1097\/MD.0000000000029611","volume":"101","author":"Y Mase","year":"2022","unstructured":"Mase Y et al (2022) Posterior scleritis with choroidal detachments and periaortitis associated with IgG4-related disease: a case report. Medicine (Baltimore) 101:e29611","journal-title":"Medicine (Baltimore)"},{"key":"396_CR198","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12886-020-01774-6","volume":"21","author":"SJ Kim","year":"2021","unstructured":"Kim SJ et al (2021) IgG4-related disease presenting as recurrent scleritis combined with optic neuropathy. BMC Ophthalmol 21:5","journal-title":"BMC Ophthalmol"},{"key":"396_CR199","doi-asserted-by":"publisher","first-page":"e795","DOI":"10.1111\/aos.13376","volume":"95","author":"F Karim","year":"2017","unstructured":"Karim F et al (2017) IgG4-related disease as an emerging cause of scleritis. Acta Ophthalmol 95:e795\u2013e796","journal-title":"Acta Ophthalmol"},{"key":"396_CR200","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00347-022-01688-2","volume":"119","author":"MC Herwig-Carl","year":"2022","unstructured":"Herwig-Carl MC, Fischer HP, Holz FG, Loeffler KU (2022) Scleritis in IgG4-related disease. Ophthalmologie 119:767\u2013768","journal-title":"Ophthalmologie"},{"key":"396_CR201","first-page":"4876587","volume":"2017","author":"E Berkowitz","year":"2017","unstructured":"Berkowitz E, Arnon E, Yaakobi A, Cohen Y, Tiosano B (2017) IgG4-Related Disease Presenting as Isolated Scleritis. Case Rep Ophthalmological Med 2017:4876587","journal-title":"Case Rep Ophthalmological Med"},{"key":"396_CR202","doi-asserted-by":"publisher","first-page":"iii123","DOI":"10.1093\/rheumatology\/kez667","volume":"59","author":"F Maritati","year":"2020","unstructured":"Maritati F, Peyronel F, Vaglio A (2020) IgG4-related disease: a clinical perspective. Rheumatology (Oxford) 59:iii123\u2013iii131","journal-title":"Rheumatology (Oxford)"},{"key":"396_CR203","doi-asserted-by":"crossref","unstructured":"Khoo LW, Srinivasan S, Roberts F (2020) Foreign body episcleral suture granulomas mimicking nodular anterior scleritis. BMJ Case Rep 13","DOI":"10.1136\/bcr-2020-237661"},{"key":"396_CR204","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/S0161-6420(03)00571-2","volume":"110","author":"S Srinivasan","year":"2003","unstructured":"Srinivasan S, Singh AK, Desai SP, Talbot JF, Parsons MA (2003) Foreign body episcleral granulomas complicating intravitreal silicone oil tamponade: a clinicopathological study. Ophthalmology 110:1837\u20131840","journal-title":"Ophthalmology"},{"key":"396_CR205","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/qjmed\/hcy295","volume":"112","author":"S Yangzes","year":"2019","unstructured":"Yangzes S, Sharma VK, Singh SR, Ram J (2019) Scleromalacia perforans in rheumatoid arthritis. QJM 112:459\u2013460","journal-title":"QJM"},{"key":"396_CR206","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/rheumatology\/keh445","volume":"44","author":"G Sakellariou","year":"2005","unstructured":"Sakellariou G, Berberidis C, Vounotrypidis P (2005) A case of Behcet\u2019s disease with scleromalacia perforans. Rheumatology (Oxford) 44:258\u2013260","journal-title":"Rheumatology (Oxford)"},{"key":"396_CR207","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/rheumatology\/keh659","volume":"44","author":"AY Chan","year":"2005","unstructured":"Chan AY, Liu DT (2005) A case of Behcet\u2019s disease with scleromalacia perforans. Rheumatology 44:1077","journal-title":"Rheumatology"},{"key":"396_CR208","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0016-5085(81)90666-1","volume":"81","author":"PJ Tesar","year":"1981","unstructured":"Tesar PJ, Burgess JA, Goy JA, Lazell RW (1981) Scleromalacia perforans in ulcerative colitis. Gastroenterology 81:153\u2013155","journal-title":"Gastroenterology"},{"key":"396_CR209","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2141.2005.05383.x","volume":"129","author":"C Hon","year":"2005","unstructured":"Hon C, Law RW, Au WY (2005) Scleromalacia perforans complicating graft-versus-host disease. Br J Haematol 129:1","journal-title":"Br J Haematol"},{"key":"396_CR210","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3928\/1542-8877-19960501-15","volume":"27","author":"M Kachmaryk","year":"1996","unstructured":"Kachmaryk M, Bouchard CS, Duffner LA (1996) Bilateral fascia lata patch grafts in a patient with progressive scleromalacia perforans. Ophthalmic Surg Lasers 27:397\u2013400","journal-title":"Ophthalmic Surg Lasers"},{"key":"396_CR211","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/ICO.0000000000002465","volume":"40","author":"K Droutsas","year":"2021","unstructured":"Droutsas K et al (2021) Treatment of progressive scleromalacia perforans by tectonic enhancement with lyophilized equine pericardium. Cornea 40:648\u2013651","journal-title":"Cornea"},{"key":"396_CR212","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/S0161-6420(99)00719-8","volume":"106","author":"WP Riono","year":"1999","unstructured":"Riono WP, Hidayat AA, Rao NA (1999) Scleritis: a clinicopathologic study of 55 cases. Ophthalmology 106:1328\u20131333","journal-title":"Ophthalmology"},{"key":"396_CR213","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.survophthal.2012.11.002","volume":"58","author":"RR Doshi","year":"2013","unstructured":"Doshi RR, Harocopos GJ, Schwab IR, Cunningham ET Jr (2013) The spectrum of postoperative scleral necrosis. Surv Ophthalmol 58:620\u2013633","journal-title":"Surv Ophthalmol"},{"key":"396_CR214","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/0002-9394(82)90535-9","volume":"93","author":"SM Salamon","year":"1982","unstructured":"Salamon SM, Mondino BJ, Zaidman GW (1982) Peripheral corneal ulcers, conjunctival ulcers, and scleritis after cataract surgery. Am J Ophthalmol 93:334\u2013337","journal-title":"Am J Ophthalmol"},{"key":"396_CR215","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1136\/bjo.84.9.1050","volume":"84","author":"Z Alsagoff","year":"2000","unstructured":"Alsagoff Z, Tan DT, Chee SP (2000) Necrotising scleritis after bare sclera excision of pterygium. Br J Ophthalmol 84:1050\u20131052","journal-title":"Br J Ophthalmol"},{"key":"396_CR216","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/bjo.2004.051359","volume":"89","author":"MR Vagefi","year":"2005","unstructured":"Vagefi MR, Hollander DA, Seitzman GD, Margolis TP (2005) Bilateral surgically induced necrotising scleritis with secondary superinfection. Br J Ophthalmol 89:124\u2013125","journal-title":"Br J Ophthalmol"},{"issue":"99","key":"396_CR217","first-page":"146","volume":"1962","author":"AJ Lyne","year":"1979","unstructured":"Lyne AJ, Lloyd-Jones D (1979) Necrotizing scleritis after ocular surgery. Trans Ophthalmol Soc U K 1962(99):146\u2013149","journal-title":"Trans Ophthalmol Soc U K"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-024-00396-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-024-00396-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-024-00396-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T15:05:01Z","timestamp":1712761501000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-024-00396-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":217,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["396"],"URL":"https:\/\/doi.org\/10.1186\/s12348-024-00396-z","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,10]]},"assertion":[{"value":"17 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent was obtained for all figures presented in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No authors have any competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}